Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.8 USD | -0.58% | -3.92% | -6.66% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.66% | 2.38B | |
+0.80% | 43.84B | |
+5.66% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.13% | 25.53B | |
-24.63% | 18.18B | |
-2.97% | 12.29B | |
+26.09% | 12.29B | |
+6.92% | 11.15B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- SVB Securities Adjusts Celldex Therapeutics' Price Target to $64 From $68, Keeps Outperform Rating